Additionally, recent reports demonstrated that miR-221/222 regulated TRAIL-resistance and enhanced tumorigenicity through PTEN and TIMP3 down-regulation in aggressive non small cell lung cancer and hepatocarcinoma cells [9]. Here, TIMP3 is linked to non-small cell lung carcinoma.